Internal Medicine · Etowah, TN
NPI
1134185358
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
301 Grady Road
Etowah, TN, 37331
Phone (423) 263-2444
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
7,547 services
Medicare patients, 2024
424
Average age 73
Drug cost, 2024
$2.1M
16,335 prescriptions
Company payments, 2025
$83K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nathan C Trentham was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,359 times for 30 patients. In total Nathan C Trentham billed 7,547 services in 122 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,359 | 30 | $0.09 | $204 |
| 99214 Office E&M - Established | Office | 734 | 361 | $76.80 | $56K |
| 36415 Venipuncture Blood Collection | Office | 558 | 272 | $8.42 | $4,699 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 431 | 258 | $11.49 | $4,951 |
| 80053 Clinical Chemistry | Office | 239 | 199 | $10.23 | $2,444 |
| 80061 Clinical Chemistry | Office | 223 | 182 | $12.77 | $2,847 |
| 85025 Blood Count | Office | 216 | 169 | $7.37 | $1,592 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 206 | 206 | $120.01 | $25K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 196 | 196 | $17.18 | $3,367 |
| 83036 Blood Count | Office | 184 | 94 | $9.11 | $1,676 |
| 99213 Office E&M - Established | Office | 177 | 131 | $54.34 | $9,618 |
| 80048 Clinical Chemistry | Office | 170 | 113 | $8.00 | $1,360 |
| 84443 Clinical Chemistry | Office | 153 | 120 | $16.36 | $2,504 |
| 81003 Clinical Chemistry | Office | 120 | 104 | $2.09 | $251 |
| 82043 Clinical Chemistry | Office | 94 | 82 | $5.60 | $526 |
By year: 2022 $108K for 2,395 services; 2023 $179K for 8,627 services; 2024 $156K for 7,547 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 558 | 272 | $8.42 | $4,699 |
| 80053 Clinical Chemistry | 239 | 199 | $10.23 | $2,444 |
| 80061 Clinical Chemistry | 223 | 182 | $12.77 | $2,847 |
| 85025 Blood Count | 216 | 169 | $7.37 | $1,592 |
| 83036 Blood Count | 184 | 94 | $9.11 | $1,676 |
| 80048 Clinical Chemistry | 170 | 113 | $8.00 | $1,360 |
| 84443 Clinical Chemistry | 153 | 120 | $16.36 | $2,504 |
| 81003 Clinical Chemistry | 120 | 104 | $2.09 | $251 |
| 82043 Clinical Chemistry | 94 | 82 | $5.60 | $526 |
| 82570 Clinical Chemistry | 94 | 82 | $5.03 | $472 |
Medicare prescription drug claims, 2024
In 2024, the drug Nathan C Trentham prescribed most often to Medicare patients was Ezetimibe, with 629 prescriptions and refills. In total Nathan C Trentham wrote 16,335 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 629 | 1,489 | 166 | $13K |
| Levothyroxine Sodium Generic | 626 | 1,386 | 134 | $4,256 |
| Rosuvastatin Calcium Generic | 576 | 1,429 | 146 | $7,384 |
| Gabapentin Generic | 534 | 732 | 102 | $5,381 |
| Atorvastatin Calcium Generic | 531 | 1,185 | 125 | $5,006 |
| Losartan Potassium Generic | 443 | 1,030 | 121 | $3,681 |
| Amlodipine Besylate Generic | 413 | 1,078 | 120 | $2,229 |
| Carvedilol Generic | 337 | 768 | 84 | $2,429 |
| Alprazolam Generic | 333 | 333 | 49 | $1,055 |
| Repatha Sureclick Evolocumab | 299 | 427 | 57 | $236K |
| Omeprazole Generic | 298 | 772 | 78 | $3,557 |
| Pioglitazone Hcl Generic | 290 | 591 | 67 | $2,410 |
| Mounjaro Tirzepatide | 225 | 236 | 42 | $246K |
| Montelukast Sodium Generic | 202 | 431 | 44 | $1,608 |
| Furosemide Generic | 195 | 332 | 37 | $1,108 |
Brand drugs: 2,846 claims; generic drugs: 13,399 claims; opioid claims: 384.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nathan C Trentham $83K ($83K in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $75K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 102 | $75K |
| Merck Sharp & Dohme LLC MRK | 10 | $6,213 |
| Novo Nordisk Inc NVO | 14 | $295 |
| Abbvie Inc. ABBV | 17 | $272 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $265 |
| Lilly USA, LLC LLY | 15 | $216 |
| Pfizer Inc. PFE | 24 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $118 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $95.35 |
| Medtronic, Inc. MDT | 5 | $91.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.